Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Open in API
Filings indexed 1,595 across all filing types
Latest filing 2024-12-27 Call Transcript
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on December 23, 2024, involving company executives and analysts/investors discussing a recent acquisition agreement with Bayer AG. The content includes detailed discussion of the acquisition, product details, financial considerations, and Q&A with analysts. The document is explicitly titled as a "Transcript of Conference Call" and contains the full text of the call including management remarks and Q&A. This matches the definition of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary. Therefore, the correct classification is Call Transcript (CT).
2024-12-27 English
Transcript of conference call held on 23rd December, 2024
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on December 23, 2024, involving company executives discussing a recent acquisition agreement with Bayer AG. The content includes detailed discussions about the acquisition, product details, market strategy, financial considerations, and Q&A with analysts. The presence of a moderator, multiple speakers, and a Q&A session confirms this is a full transcript of a conference call. The document explicitly states it is a "Transcript of Conference Call" and contains detailed dialogue rather than a summary or announcement. Therefore, the document fits the category of a Call Transcript (CT).
2024-12-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading restrictions around the announcement of the company's un-audited financial results for the quarter and nine months ending December 31, 2024. The document is an intimation to the stock exchanges and does not contain any financial results or detailed report itself. It is a regulatory announcement related to insider trading compliance rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2106 characters), and it is clearly an announcement, not the report itself.
2024-12-24 English
Intimation of Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a notice from Dhanuka Agritech Ltd. informing the stock exchanges about the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period during which insiders are restricted from trading shares due to possession of unpublished price sensitive information related to the upcoming un-audited financial results for the quarter and nine months ending December 31, 2024. The document does not contain any financial data or results itself, nor does it announce or present a report. It is a regulatory compliance announcement related to insider trading restrictions ahead of financial results disclosure. Given the short length (2106 characters) and the nature of the content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the availability of an audio recording of an analysts/investors call related to the acquisition of international rights for certain active ingredients. It includes a link to the audio recording but does not contain the transcript or detailed financial data itself. The document references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, which governs disclosure of material events. Since this is an announcement about the availability of a call recording rather than the call transcript itself, it does not qualify as a Call Transcript (CT). It is also not a financial report or other regulatory filing. Given the nature of the document as an announcement of an event disclosure, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-12-23 English
Audio Recording of Analysts/Investors Call pertaining to the acquisition of international rights for the active ingredients 'Iprovalicarb' and 'Triadimenol' by the Company from Bayer AG, Germany.
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the availability of an audio recording of an analysts/investors call. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about providing a link to the audio recording of a call related to an acquisition. There is no financial data, no detailed transcript, no report attached or summarized, and the document is only notifying the exchange about the availability of the call recording. This fits the category of a Call Transcript (CT) announcement, but since the actual transcript is not included and only a link to the audio recording is provided, it is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure that does not contain the full transcript or financial data. The document length is short (1557 characters), and it is an announcement rather than the transcript itself. Therefore, the best classification is Regulatory Filings (RNS).
2024-12-23 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.